Head and Neck Cancer Drugs Market Growth Accelerated by Increased Adoption of Targeted Therapy Drugs

 


Head and neck cancer refers to a group of cancers that start in the mouth, nose, throat, larynx, sinuses, or salivary glands. The global head and neck cancer drugs market includes various product segments such as targeted therapy drugs, chemotherapy drugs, immunotherapy drugs, and other supportive care drugs that are used in the treatment of head and neck cancers. Targeted therapy drugs consist of drugs that block the ability of cancer cells to grow and spread such as cetuximab, nimotuzumab, and pembrolizumab. The adoption of targeted therapy drugs has increased substantially over the recent past due to their high specificity and fewer side effects as compared to chemotherapy drugs. The global head and neck cancer drugs market is estimated to be valued at US$ 1986.3 Mn in 2023 and is expected to exhibit a CAGR of 8.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

The increased adoption of targeted therapy drugs is one of the major trends being witnessed in the head and neck cancer drugs market growth. Targeted therapy drugs selectively attack cancer cells while sparing normal cells. They are known to be more effective with fewer side effects compared to chemotherapy. The success rates of targeted drugs have encouraged oncologists to use them as the first line of treatment in many cases. Furthermore, the launch of combination therapies consisting of targeted drugs along with chemotherapy and immunotherapy is expected to boost market growth over the forecast period.

Segment Analysis
Head and Neck Cancer Drugs Market
The global Head and Neck Cancer Drugs Market is dominated by the squamous cell carcinoma sub segment. Squamous cell carcinomas accounts for over 90% of all head and neck cancers. This is because squamous cells are the main cell type found in the mucosal lining of the oral cavity, larynx and pharynx. These areas have higher exposure to risk factors like tobacco and alcohol consumption which increase the chances of developing squamous cell carcinoma.

Key Takeaways
The global Head and Neck Cancer Drugs market is expected to witness high growth over the forecast period of 2023 to 2030.

Regional analysis: North America is currently the dominant region in the Head and Neck Cancer Drugs market and is expected to maintain its leading position over the forecast period as well. This is attributed to factors such as high prevalence of head and neck cancers, strong healthcare infrastructure and increasing government support for cancer research. Asia Pacific is expected to be the fastest growing region owing to large patient pool, rising health awareness, improving healthcare facilities and increasing incidence of head and neck cancers.

Key players operating in the Head and Neck Cancer Drugs market are Johnson & Johnson Services, Inc. (DePuy Synthes), Double Medical Technology Inc., Orthofix Holdings, Inc., Ortho-SUV Ltd., Response Ortho LLC, Smith & Nephew, Stryker Corporation, Zimmer Biomet, Auxein Medical, Acumed, Tasarimmed T?bbi Mamuller San. Tic A.?, Orthopaedic Implant Company (€œOIC€), Gexfix SA, WishBone Medical, Inc., and Matrix Meditech.

Get more insights on this topic: https://www.newsstatix.com/head-and-neck-cancer-drugs-market-share-and-opportunity-analysis/

Comments

Post a Comment

Popular posts from this blog

Blast Chillers Market Poised to Witness High Growth Owing to Rising Focus on Food Safety

Image
  Blast Chillers Market Blast chillers, also known as shock freeze machines, are appliances used to quickly cool or freeze food items that have been cooked. Blast chillers allow rapid and accurate chilling of cooked or cooked/hot foods quickly to temperatures that inhibit the growth of harmful bacteria. This rapid chilling process helps restaurants, cafes, caterers and foodservice distributors maintain food quality as well as meet critical food safety regulations. Blast chillers help in preserving the look, texture, flavor and nutritional value of foods even after rapid chilling. They extend the shelf life of cooked foods by preventing bacterial growth in the food's temperature danger zone — between 4°C and 60°C. With increasing focus on food safety, hygiene and quality across the foodservice industry, demand for blast chillers has been rising significantly. The Global blast chillers market is estimated to be valued at US$ 2.24 Bn in 2024 and is expected to exhibit a CAGR of 15%...
Read more

Driving Forces and Strategic Insights: Unveiling Growth Opportunities in the Global Pharma 4.0 Market

Image
  Global Pharma 4.0 Market The Global Pharma 4.0 Market is witnessing unprecedented growth driven by several factors. One of the key market drivers is the increasing adoption of digitalization and automation in the pharmaceutical industry. Pharma 4.0 represents the integration of advanced technologies such as artificial intelligence, big data analytics, Internet of Things (IoT), and robotics into pharmaceutical manufacturing and supply chain processes. This integration enhances efficiency, reduces costs, and improves the quality of pharmaceutical products. Additionally, the rising demand for personalized medicine and the need for efficient drug development processes are further fueling the growth of the Global Pharma 4.0 Market. The Global Pharma 4.0 Market is estimated to be valued at   US$ 54.43 Bn in 2024 and is expected to exhibit a CAGR of 18.3% over the forecast period from 2024 to 2031.   Conducting a PEST analysis provides insights into the external facto...
Read more

Navigating Growth: Insights into the Global Flea, Tick, and Heartworm Products Market

Image
  Global Flea, Tick, and Heartworm Products Market The Global Flea, Tick, and Heartworm Products Market have witnessed robust growth in recent years, driven by several key factors. Market drivers such as increasing pet ownership, rising awareness about pet health, and the growing prevalence of flea, tick, and heartworm infections among pets are propelling the demand for related products. Furthermore, advancements in veterinary medicines and the introduction of novel products with improved efficacy are augmenting market growth. The rising disposable income and changing lifestyles, particularly in emerging economies, have also contributed significantly to the expansion of the Global Flea, Tick, and Heartworm Products Market. The Global Flea, Tick, and Heartworm Products Market is estimated to be valued at US$ 3.14 Bn in 2024 and is expected to exhibit a CAGR of 8.5% over the forecast period 2024 to 2031. Conducting a PEST analysis provides valuable insights into the external f...
Read more